DTHF WELCOMES EARLY DATA FROM ENSEMBLE TRIAL, SHOWING SAFETY & EFFICACY FOR SINGLE -SHOT JANSSEN COVID-19 VACCINE CANDIDATE

Johnson & Johnson today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating its investigational single-dose COVID-19 vaccine met all primary and key secondary endpoints. The topline safety and efficacy data are based on 44,325 44 participants accruing 468 symptomatic cases of COVID-19. The Desmond Tutu Health Foundation is a…

Efficacy Results announced: global first Antibody Mediated Prevention (AMP) trials

Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains.   The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains that were sensitive to the bnAb. This was assessed by a laboratory test that measures a virus’…

DTHF Patron Archbishop Desmond Tutu Receives Human Rights Global Treasure Award

Another recognition of his lifelong dedication to advancing peace and equality, Archbishop Desmond Tutu has been awarded the ‘Human Rights Global Treasure’ Award The award was announced during a virtual programme on International Human Rights Day, Thursday 10 December. The event included a conversation with four former UN High Commissioners for Human Rights – Mary…